Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-cell profiling unveils an exhaustion trajectory of ZNF683<sup>hi</sup> tissue-resident alveolar CD8<sup>+</sup> T cells in checkpoint inhibitor pneumonitis.

Med (New York, N.Y.)·2026
Same author

Quantitative metabolomics identifies prognostic biomarkers associated with NSCLC after chemoradiotherapy.

The Analyst·2026
Same author

The <i>Ganoderma lucidum</i> and <i>Rosa roxburghii</i> Tratt Formulation Prevents Depressive-like Behaviors in Mice by Modulating Tryptophan Metabolism via the Gut-Brain Axis and Upregulating the BDNF/TrkB/PI3K/AKT Pathway.

Foods (Basel, Switzerland)·2026
Same author

Long-term outcomes and clinical features of stage III non-small-cell lung cancer harboring ALK rearrangements: a multicenter retrospective study of 176 patients.

Journal of the National Cancer Center·2026
Same author

Quantifying statistical cure in unresectable locally advanced esophageal squamous cell carcinoma treated with radiotherapy-based regimens: a cure model analysis with SEER validation.

Frontiers in oncology·2026
Same author

Comparing the Prognosis of Non-Small Cell Lung Cancer Patients Who Did Not Undergo Surgery After Neoadjuvant Chemotherapy Combined With Immunotherapy: A Retrospective Study.

Thoracic cancer·2026

Related Experiment Video

Updated: Dec 24, 2025

A Strategy for Sensitive, Large Scale Quantitative Metabolomics
14:18

A Strategy for Sensitive, Large Scale Quantitative Metabolomics

Published on: May 27, 2014

21.5K

Development of a high-coverage metabolome relative quantitative method for large-scale sample analysis.

Zhi Zhou1, Yanhua Chen1, Yang Gao2

  • 1State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, 100050, PR China; Center for Bioimaging & System Biology, Minzu University of China, Beijing, 100081, PR China.

Analytica Chimica Acta
|April 8, 2020
PubMed
Summary

This study introduces an improved quantitative metabolomics method for analyzing large sample sets, successfully quantifying over 1000 metabolites in human plasma and identifying 26 lung cancer biomarkers.

Keywords:
High-coverage analysisLarge-scale sample sizeLiquid chromatography-tandem mass spectrometryRelative quantitative metabolomics

More Related Videos

Large Scale Non-targeted Metabolomic Profiling of Serum by Ultra Performance Liquid Chromatography-Mass Spectrometry UPLC-MS
07:34

Large Scale Non-targeted Metabolomic Profiling of Serum by Ultra Performance Liquid Chromatography-Mass Spectrometry UPLC-MS

Published on: March 14, 2013

13.2K
Untargeted Metabolomics from Biological Sources Using Ultraperformance Liquid Chromatography-High Resolution Mass Spectrometry UPLC-HRMS
11:00

Untargeted Metabolomics from Biological Sources Using Ultraperformance Liquid Chromatography-High Resolution Mass Spectrometry UPLC-HRMS

Published on: May 20, 2013

23.2K

Related Experiment Videos

Last Updated: Dec 24, 2025

A Strategy for Sensitive, Large Scale Quantitative Metabolomics
14:18

A Strategy for Sensitive, Large Scale Quantitative Metabolomics

Published on: May 27, 2014

21.5K
Large Scale Non-targeted Metabolomic Profiling of Serum by Ultra Performance Liquid Chromatography-Mass Spectrometry UPLC-MS
07:34

Large Scale Non-targeted Metabolomic Profiling of Serum by Ultra Performance Liquid Chromatography-Mass Spectrometry UPLC-MS

Published on: March 14, 2013

13.2K
Untargeted Metabolomics from Biological Sources Using Ultraperformance Liquid Chromatography-High Resolution Mass Spectrometry UPLC-HRMS
11:00

Untargeted Metabolomics from Biological Sources Using Ultraperformance Liquid Chromatography-High Resolution Mass Spectrometry UPLC-HRMS

Published on: May 20, 2013

23.2K

Area of Science:

  • Metabolomics
  • Biomarker Discovery
  • Translational Research

Background:

  • Quantitative metabolomics is crucial for standardized and translational applications.
  • Existing methods struggle with large sample sizes and comprehensive metabolite quantification.
  • Data-independent targeted quantitative metabolomics (DITQM) offers ion pair information for 1324 metabolites.

Purpose of the Study:

  • To develop an enhanced quantitative metabolomics approach for large-scale studies.
  • To improve metabolite quantification coverage and data handling efficiency.
  • To identify potential biomarkers for lung cancer detection.

Main Methods:

  • Developed scheduled multiple reaction monitoring (MRM) methods for high- and low-abundant metabolites based on DITQM.
  • Created an open-source program "Quanter_1.0" for efficient data processing.
  • Applied the method to a large-scale lung cancer study across three analytical batches.

Main Results:

  • Successfully quantified 1015 metabolites in human plasma with effective relative determination.
  • Demonstrated improved data quality with reduced intra- and inter-batch variation in quantitative metabolomics.
  • Identified 26 potential lung cancer biomarkers from the large-scale study.
  • Achieved a more effective multivariate statistical model due to enhanced data quality.

Conclusions:

  • The developed quantitative metabolomics approach enables effective analysis of large sample sizes.
  • The method improves data quality and reduces variability for robust statistical modeling.
  • This approach is a promising tool for large-scale metabolomics research and clinical applications, including biomarker discovery.